Ringraf 1.0mg Tablet
Manufacturer
Rindz Pharma
Salt Composition
Tacrolimus (1.0mg)
Key Information
Short Description
Ringraf 1.0mg Tablet is used along with other medicines to prevent your body from rejecting a new organ (e.g., liver, kidney, or heart) after transplant.
Dosage Form
Tablet
Introduction
Ringraf 1.0mg Tablet is an immunosuppressant used to prevent organ rejection in transplant patients. It works by suppressing the body's immune response following the transplant of an organ, helping the body to accept the new organ as if it were its own.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ringraf 1.0mg Tablet is to be taken empty stomach.
How it works
Ringraf 1.0mg Tablet is an immunosuppressant. It works by suppressing your body's immune response following the transplant of an organ (e.g., liver, kidney, or heart). This helps your body to accept the new organ as if it were your own.
Quick Tips
Ringraf 1.0mg Tablet is used to prevent organ rejection in transplant patients. It may take 3 to 4 months for the medication to work. Keep taking it as prescribed. Your doctor may get regular blood tests done to check the levels of blood cells in your blood. Inform your doctor if you experience unexplained bruising or bleeding, sore throat, mouth ulcers, fever, or general illness. Your doctor may monitor your kidney function regularly. Drink 8 to 10 glasses of water per day to help with your kidney function. Do not stop taking Ringraf 1.0mg Tablet without talking to your doctor first.
Frequently asked questions
Is Ringraf 1.0mg Tablet an antibiotic?
Yes, Ringraf 1.0mg Tablet is an antibiotic that belongs to a group of medicines called macrolides. It is primarily used after organ transplantation. This medicine's immune-suppressing properties help prevent organ rejection after kidney, heart, or liver transplant.
Which vaccines should not be taken while taking Ringraf 1.0mg Tablet?
You should avoid taking live vaccines (vaccines that use pathogens that are still alive but are attenuated, meaning weakened) while taking Ringraf 1.0mg Tablet. These may include vaccinations for measles, mumps, rubella, BCG (TB vaccine), yellow fever, chicken pox and typhoid. You should also avoid taking polio drops (by mouth) or flu vaccine (through nose).
Who should not take Ringraf 1.0mg Tablet?
Patients with allergies to it or a weakened immune system, high blood pressure, and kidney failure should avoid Ringraf 1.0mg Tablet. This medicine also needs to be avoided in pregnant or breastfeeding women, as well as those planning to receive any live vaccines (e.g. MMR vaccine).
What should I tell my doctor before taking Ringraf 1.0mg Tablet?
Inform your doctor if you are pregnant, have allergies, a long-term infection, high blood sugar, or high blood pressure. You should also inform your doctor if you have high blood potassium levels or a weakened immune system. Tell your doctor if you have a history of any medication, have recently received, or are scheduled to receive a live vaccine.
What should I be aware of before I start taking Ringraf 1.0mg Tablet?
This medicine suppresses the immune system, so there is always an increased risk of infection. Additionally, in some cases, Ringraf 1.0mg Tablet can increase the risk of certain cancers like skin and lymph gland cancer (lymphoma). It can lower your immune system's ability to fight infections. Consult with your doctor before starting this medication and if you notice any symptoms of infections such as fever, sweats or chills, cough, flu-like symptoms, muscle aches, warm, red, or painful areas on your skin.
Does Ringraf 1.0mg Tablet have an abuse potential?
No, Ringraf 1.0mg Tablet does not have an abuse potential and is therefore not a controlled substance. Controlled substances are those with potential for abuse; they require authorization from authorities and doctors before use.
